Cargando…

Dopamine D3 Receptor: Contemporary Views of Its Function and Pharmacology for Neuropsychiatric Diseases

Detalles Bibliográficos
Autores principales:	De Deurwaerdère, Philippe, Chagraoui, Abdeslam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151522/ https://www.ncbi.nlm.nih.gov/pubmed/34064602 http://dx.doi.org/10.3390/biom11050713

Ejemplares similares

Editorial: Contemporary Perspective on 5-HT(2C) Receptor Function and Its Pharmacological Targeting
por: De Deurwaerdère, Philippe, et al.
Publicado: (2020)

Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease
por: Chagraoui, Abdeslam, et al.
Publicado: (2022)

Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain
por: Di Giovanni, Giuseppe, et al.
Publicado: (2020)

Effect of the 5-HT(2C) Receptor Agonist WAY-163909 on Serotonin and Dopamine Metabolism across the Rat Brain: A Quantitative and Qualitative Neurochemical Study
por: Whitestone, Sara, et al.
Publicado: (2019)

Editorial: New GPCR targets and modulators to treat CNS disorders
por: De Deurwaerdère, Philippe, et al.
Publicado: (2022)

Chronic Administration of Fipronil Heterogeneously Alters the Neurochemistry of Monoaminergic Systems in the Rat Brain
por: Bharatiya, Rahul, et al.
Publicado: (2020)

A Subset of Purposeless Oral Movements Triggered by Dopaminergic Agonists Is Modulated by 5-HT(2C) Receptors in Rats: Implication of the Subthalamic Nucleus
por: Lagière, Mélanie, et al.
Publicado: (2020)

L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning
por: Chagraoui, Abdeslam, et al.
Publicado: (2019)

Functional and pharmacological role of the dopamine D(4) receptor and its polymorphic variants
por: Ferré, Sergi, et al.
Publicado: (2022)

Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats
por: De Deurwaerdère, Philippe, et al.
Publicado: (2022)

Limiting Monoamines Degradation Increases L-DOPA Pro-Locomotor Action in Newborn Rats
por: Khsime, Inès, et al.
Publicado: (2023)

The Signaling and Pharmacology of the Dopamine D1 Receptor
por: Jones-Tabah, Jace, et al.
Publicado: (2022)

Sex Differences in Dopamine Receptors and Relevance to Neuropsychiatric Disorders
por: Williams, Olivia O. F., et al.
Publicado: (2021)

Targeting dopamine receptor D3 signalling in inflammation
por: Pacheco, Rodrigo
Publicado: (2017)

Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor
por: Adhikari, Pramisha, et al.
Publicado: (2021)

Cardiovascular Pharmacology: Contemporary Physiologic and Scientific Approaches to Cardiovascular Disease Prevention and Treatment
por: Young, James B., et al.
Publicado: (2022)

Serotonin in Health and Disease
por: De Deurwaerdère, Philippe, et al.
Publicado: (2020)

Pathophysiology of the Serotonin System in the Nervous System and Beyond
por: De Deurwaerdère, Philippe, et al.
Publicado: (2022)

A Neuropsychiatric View of Insomnia
por: Warren, P. K. G.
Publicado: (1970)

Contemporary Western Medicine has its pitfalls
por: English, Denis
Publicado: (2019)

Ultra‐high‐field pharmacological functional MRI of dopamine D1 receptor‐related interventions in anesthetized rats
por: Kimura, Yuka, et al.
Publicado: (2023)

Dopamine D(2) Receptors Dimers: How can we Pharmacologically Target Them?
por: Carli, Marco, et al.
Publicado: (2018)

Enantioenriched Positive Allosteric Modulators Display Distinct Pharmacology at the Dopamine D(1) Receptor
por: Fyfe, Tim J., et al.
Publicado: (2021)

Editorial: Insights on neuroinflammatory response by microglia-targeted pharmacology
por: Raber, Jacob, et al.
Publicado: (2023)

Imaging of Dopamine in PD and Implications for Motor and Neuropsychiatric Manifestations of PD
por: de la Fuente-Fernández, Raúl
Publicado: (2013)

Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease
por: Chen, Allen PF, et al.
Publicado: (2021)

Enhanced Dopamine Transmission and Hyperactivity in the Dopamine Transporter Heterozygous Mice Lacking the D3 Dopamine Receptor
por: Sotnikova, Tatyana D., et al.
Publicado: (2020)

Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma
por: Yan, Yan, et al.
Publicado: (2020)

Contemporary Teaching Approches in Pharmacology
Publicado: (2008)

Fluorescent ligands for dopamine D(2)/D(3) receptors
por: Allikalt, Anni, et al.
Publicado: (2020)

Functional Regulation of Dopamine D(3) Receptor through Interaction with PICK1
por: Zheng, Mei, et al.
Publicado: (2016)

Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release
por: Berry, Anne S, et al.
Publicado: (2018)

Dopamine Receptors and the Kidney: An Overview of Health- and Pharmacological-Targeted Implications
por: Olivares-Hernández, Alejandro, et al.
Publicado: (2021)

Pharmacological and Genetic Evidence of Dopamine Receptor 3-Mediated Vasoconstriction in Isolated Mouse Aorta
por: Zingales, Veronica, et al.
Publicado: (2021)

Dopamine D(4) receptor, but not the ADHD-associated D(4.7) variant, forms functional heteromers with the dopamine D(2S) receptor in the brain
por: González, Sergio, et al.
Publicado: (2011)

Novel Therapeutic Drugs for Neuropsychiatric Disorders
por: Hashimoto, Kenji
Publicado: (2010)

The role of sex and gender in neuropsychiatric disorders
por: Thibaut, Florence
Publicado: (2016)

Neuroinflammation: new vistas for neuropsychiatric research
por: Thibaut, Florence
Publicado: (2017)

International Neuropsychiatric Association
por: Sachdev, Perminder
Publicado: (2005)

Presynaptic action of neurotensin on dopamine release through inhibition of D(2 )receptor function
por: Fawaz, Charbel S, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_viv6ev9qpr8nqsoddq4t9rnjfn